1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh J.H., Brenner B.M. (eds). Hypertension: pathophysiology, diagnosis and management. New York: Raven Press 1990;1287−317.
2. Vallotton MB. The renin-angiotensin system. Trends Pharmacol Sci 1987;8:69−74.
3. Dzau VJ, Pratt RE. Renin-angiotensin system: biology, physiology and pharmacology. In: Haber E, Morgan H, Katz A, Fosard (eds). Handbook of experimental cardiology. New York: Raven Press, 1986: D1631−61.
4. Kurtz A, Scholz H, Della-Bruna R. Molecular mechanism of renin release. J Cardiovasc Pharmacol 1990;16(suppl 4):51−7.
5. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977;57:313−70.
6. Dzau VJ, Gibbons JH. Autocrine-paracrine mechanisms of vascular myocytes in hypertension. Am J Cardiol 1987;60:991−1031.
7. Dzau VJ, Hirch AT. Emerging role of the tissue renin-angiotensin systems in congestive heart failure. Eur Heart J 1990;11:65−71.
8. Grinstead WC, Young JB. The myocardial renin-angiotensin system: existence, importance and clinical implications. Am Heart J 1992;123:1039−45.
9. Dzau VJ. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Bas Res Cardiol 1993;88:1−14.
11. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988;77(suppl I):I4−13.
12. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849−65.
13. Urata H, Boehm KD, Philip A, et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269−81.
14. Stoll M, Steckelings UM, Paul M, et al. The AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651−7.
15. Nakajima M, Hutchinson HG, Fujinaga M, et al. The AT2 receptor antagonizes the growth effects of the AT1 receptor: gain of function study using gene transfer. Proc Natl Acad Sci 1995;92:10 663−7.
16. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci 1996;93:156−60.
17. Timmermans PBMWM, Benfield P, Chiu AT, et al. Angiotensin II receptors and functional correlates. Am J Hypertens 1992;5:221−35S.
18. Hall JE, Brands MW. Intrarenal and circulating angiotensin II and renal function. In: Robertson JIS, Nichols MG, eds. The Renin-Angiotensin System. London: Gower Medical, 1993.
19. Packer M, Lee WH, Kessler PD, et al. Role of neurohumoral mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987;75(suppl IV):IV80−92.
20. Pouleur H, Konstram MA, Benedict CR, et al. Progression of left ventricular dysfunction during enalapril therapy: relationship with neurohormonal reactivation. Circulation 1993;88:I-293A.
21. Rousseau MF, Konstam MMA, Benedict CR, et al. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting-enzyme inhibitor. Am J Cardiol 1994;73:488−93.
